Post by VUGENE

We are proud to see Karolina Žukauskienė, Scientific Project Manager at VUGENE — a specialist in multi-omics data analysis and interpretation, featured in an interview titled "𝗕𝗜𝗢 𝟮𝟬𝟮𝟲: 𝗕𝗲𝘆𝗼𝗻𝗱 𝘁𝗵𝗲 𝗗𝗡𝗔 𝗕𝗹𝘂𝗲𝗽𝗿𝗶𝗻𝘁," published in The Pharma Navigator. In this video interview, she explains that while DNA provides a baseline for research and development, unlocking true biological complexity requires integrating dynamic multi-omics datasets. “Historically, genomics was the first omic discipline to achieve large-scale standardization,” specifies Žukauskienė. That standardization afforded a dramatic reduction in cost of drug discovery and allowed companies to mature their pipelines more rapidly, she notes. “Naturally, the industry focused on extracting as much value as possible from DNA-based information,” Žukauskienė continues. “However, biology is dynamic, and DNA really provides a good basis, it’s a footprint, a blueprint, but it doesn’t fully explain how the cells interact, how disease develops, how disease evolves, and how the treatment works once injected.” Read more about integrating dynamic multi-omics datasets on VUGENE website: https://lnkd.in/dt4pkCwM VUGENE democratizes access to powerful multi-omics analysis through a customizable, scalable AI/ML platform. It accelerates therapeutic R&D by combining deep biological insights with scientific expertise and human intelligence – turning large, raw datasets into informed and actionable R&D decisions. Watch the full interview: https://lnkd.in/dGeNBE39 #VUGENE #DataAnalysis #multiomics #bioinformatics #datascience #research